Abstract
This study aims to describe and understand the relationship between sociodemographic factors and PrEP awareness, and willingness to use a PrEP modality (oral or injectable).Despite the availability of effective prevention tools such as HIV preexposure prophylaxis (PrEP), African immigrants in the United States are disproportionately affected by HIV. Although PrEP can significantly reduce HIV infection in this population, research evidence on PrEP outcomes, such as awareness, knowledge, and willingness to use, is extremely limited. Between April and May 2022, 92 participants completed an online survey assessing their awareness, knowledge, and willingness to use oral or injectable PrEP. The association between sociodemographic characteristics and PrEP-related measures was examined using descriptive and Pearson’s chi-squared or Fisher’s exact tests. Participants (N = 92) were born between 1990 and 1999 (46.7%), female (70.76%) and highly educated (59.6%). About 52.2% were unaware of PrEP, and 65.6% were willing to use a PrEP modality. Findings indicate that individuals who reported being aware of PrEP demonstrated a high level of knowledge regarding the medication. Having a healthcare provider was associated with PrEP awareness and willingness to use, while educational status was associated with PrEP awareness. 51.1% of participants were willing to use an oral pill for prevention and 47.8% were willing to use injectable PrEP. Our findings highlight the need for PrEP-related research and interventions for African immigrants to increase awareness and provide options for HIV prevention, as African immigrants are currently not well-represented in PrEP delivery systems in the US.
Similar content being viewed by others
Data Availability
The datasets generated and/or analyzed during the current study are not publicly available due to it still being used for primary analyses but are available from the corresponding author on reasonable request.
References
Blanas DA, et al. HIV/AIDS among African-born residents in the United States. J Immigr Minor Health. 2013;15(4):718–24.
Demeke H, et al. Differences between U.S.-Born and Non-U.S.-Born black adults reported with diagnosed HIV infection: United States, 2008–2014. J Immigr Minor Health. 2019;21(1):30–8.
Kerani R, et al. Foreign-born individuals with HIV in King County, WA: a glimpse of the future of HIV? AIDS Behav. 2017;22(7):2181–8.
Koku EF, et al. HIV/AIDS among African Immigrants in the U.S.: the need for disaggregating HIV Surveillance Data by Country of Birth. J Health Care Poor Underserved. 2016;27(3):1316–29.
Tamir C, Anderson M. One-in-ten Black People living in the U.S. are immigrants. Pew Research Center; 2022.
Kerani RP, et al. Post-migration HIV acquisition among african immigrants in the U.S. J Immigr Minor Health. 2022;24(6):1459–68.
Kerani RP, et al. The epidemiology of HIV among People born outside the United States, 2010–2017. Public Health Rep. 2020;135(5):611–20.
Centers for Disease Control and Prevention. Pre-Exposure Prophylaxis (PrEP). 2019 September 29,]; Available from: https://www.cdc.gov/hiv/pdf/library/factsheets/prep101-consumer-info.pdf.
Baeten JM, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.
Anderson PL, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.
Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update: a clinical practice guideline. 2022; Available from: https://www.cdc.gov/hiv/clinicians/prevention/prep.html#:~:text=Emtricitabine%20(F)%20200%20 mg%20in,(brand%20name%20Apretude%C2%AE).
Pinto RM, et al. Improving PrEP implementation through multilevel interventions: a synthesis of the literature. AIDS Behav. 2018;22(11):3681–91.
Okoro O, Whitson S. Sexual health, HIV Care and Pre-exposure Prophylaxis in the african immigrant Population: a needs Assessment. J Immigr Minor Health, 2019: p. 1–11.
Aidoo-Frimpong G, et al. Exploring awareness, perceptions, and willingness to Use HIV Pre-Exposure Prophylaxis: a qualitative study of Ghanaian Immigrants in the United States. AIDS Patient Care STDS. 2022;36(1):8–16.
Aidoo-Frimpong G, et al. Barriers to HIV Pre-Exposure Prophylaxis Uptake and Ways to mitigate them: perspectives of Ghanaian Immigrants in the United States. AIDS Educ Prev. 2022;34(3):209–25.
Muhumuza R, et al. Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa. Arch Sex Behav. 2021;50(4):1729–42.
Sam F. Why WhatsApp is not social media, in Medium.com. 2018.
Cudjoe J, et al. Recruiting african immigrant women for community-based Cancer Prevention Studies: Lessons learned from the AfroPap Study. J Community Health. 2019;44(5):1019–26.
Aidoo-Frimpong G et al. WhatsApp-propriate? Exploring “WhatsApp” as a Tool for Research Among Ghanaian Immigrants in the United States. J Racial Ethn Health Disparities, 2023: p. 1–8.
Markowitz M, et al. Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial. The lancet HIV. 2017;4(8):e331–40.
Auerbach JD, et al. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDs. 2015;29(2):102–10.
Mwaturura C et al. Barriers and facilitators to pre-exposure prophylaxis among african migrants in high income countries: a systematic review. Sex Health, 2021.
Bleasdale J, et al. Prescribing HIV pre-exposure prophylaxis: a qualitative analysis of health care provider training needs. J HIV/AIDS Social Serv. 2020;19(1):107–23.
Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure Prophylaxis in the United States: a narrative review. Adv Therapy. 2020;37(5):1778–811.
Acknowledgements
The authors wish to thank the participants who generously contributed their time, and Iyobosa Ekhator for her help with recruitment.
Funding
This work was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo.
Author information
Authors and Affiliations
Contributions
The authors confirm contribution to the paper as follows: study conception and design: Gloria Aidoo-Frimpong, Kafuli Agbemenu, LaRon E. Nelson; data collection: Gloria Aidoo-Frimpong, Kafuli Agbemenu; analysis and interpretation of results: David Adzrago, Sarpong Boateng, Samuel Akyirem; draft manuscript preparation: Gloria Aidoo-Frimpong, Kafuli Agbemenu, Sarpong Boateng, David Adzrago, Samuel Akyirem; draft manuscript revision and finalization: Gloria Aidoo-Frimpong, Kafuli Agbemenu, and Laron E. Nelson. All authors have read and approved the submitted version of the manuscript. All authors have read and approved the submitted version of the manuscript.
Corresponding author
Ethics declarations
Ethics Approval
This work is in accordance with the ethical standards of the University at Buffalo’s institutional review board and with the 1964 Helsinki declaration and its later amendments.
Consent to Participate
Informed Consent was obtained from all participants.
Competing interests
The authors report there are no competing interests to declare.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Aidoo-Frimpong, G., Agbemenu, K., Adzrago, D. et al. The Promise of Pre-Exposure Prophylaxis – Examining Awareness, Knowledge, and Willingness to use Different Modalities Among US-Based African Immigrants. J Immigrant Minority Health 25, 1331–1338 (2023). https://doi.org/10.1007/s10903-023-01515-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10903-023-01515-z